ASTH today
$32.53-$0.34 (-1.03%)close Nov 17, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bullish
15 minStrong Bullish
5 minBearish
Daily trend turns up above $41.00
Key levels
Resistance$38.77
Resistance$35.65
Support$32.22
Support$29.33
Latest news & SEC filings
AnalystNeedham keeps Buy rating on Astrana Health, lifts target to $45
EarningsAstrana Health holds Q3 2026 earnings call
All ASTH news →About Astrana Health
Astrana Health runs a medical care business built around physicians and technology, taking on financial risk for patient populations. Its operations fall into three segments: Care Partners, which organizes independent doctors and accountable care groups into risk-bearing networks; Care Delivery, which covers clinics, a hospital, imaging and surgery centers, labs, and a pharmacy; and Care Enablement, which supplies software and administrative support to doctors and insurers. Patients are mainly those with Medicare, Medicaid, commercial, or exchange coverage, and activities are concentrated in the United States.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Industrials
Astrana Health, Inc. (ASTH)
What Is the Price Target for ASTH?
SEPT Low Target
$40.00
SEPT Mid Target
$51.50
SEPT High Target
$65.00
Analyst Consensus
$51.50
Is ASTH a Buy or Sell Right Now?
Thesis
- •Revenue growing 56.4% YoY with ACCELERATING trend — accelerating momentum.
Test your own strategy on ASTH
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on ASTH with SEPT’s own market data.
Start Free Trial →Is ASTH Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$47.94
23
Moat Score
NONE
3/9
Piotroski Score
2.5
Altman Z-Score
What Is Smart Money Doing with ASTH?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Vong John | officer | Sale | 642 | $20K | Nov 12, 2026 |
| Sim Brandon | officer | Sale | 9,889 | $366K | Oct 6, 2026 |
| Lam Thomas S. | director | Sale | 2,624 | $97K | Oct 6, 2026 |
| Basho Chandan | officer | Sale | 2,092 | $75K | Oct 2, 2026 |
| Kitayama Mitchell W | director | Sale | 8,500 | $315K | Aug 31, 2026 |
| Schmidt David | director | Buy | 4,525 | - | Jun 10, 2026 |
| Mazdyasni Matthew | director | Buy | 4,525 | - | Jun 10, 2026 |
| Kitayama Mitchell W | director | Buy | 4,991 | - | Jun 10, 2026 |
| Dong Linda | director | Buy | 4,525 | - | Jun 10, 2026 |
| Dai, Weili | director | Buy | 4,525 | - | Jun 10, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →ASTH Growth Story
Revenue YoY
56.4%
3yr Revenue CAGR
40.6%
EPS Growth YoY
-48.89%
FCF Growth YoY
136.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for ASTH
PREVIEWRecent off-exchange (dark pool) prints for ASTH: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:10 | $32.87 | 1,000 | $$33K | SELL |
| 18:59:49 | $32.88 | 2,000 | $$66K | BUY |
| 17:48:32 | $32.41 | 1,375 | $$45K | BUY |
| 16:12:16 | $32.36 | 1,100 | $$36K | SELL |
| 15:01:45 | $32.10 | 1,100 | $$35K | SELL |
5 dark pool trades shown · $$214K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Astrana Health, Inc. (ASTH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →ASTH — frequently asked questions
What is ASTH stock price today?
Astrana Health, Inc. (ASTH) is at $32.53, down 1.03% (-$0.34) at the Nov 17, 2026 close.
Why is ASTH stock moving today?
Latest ASTH news — Nov 6, 2026: Needham keeps Buy rating on Astrana Health, lifts target to $45 · Nov 5, 2026: Astrana Health holds Q3 2026 earnings call
What is the ASTH price target?
The average analyst price target for ASTH is $51.50, ranging from $40 to $65, based on 8 analysts. Latest: Oppenheimer initiates on Sep 15, 2026.
What do analysts rate ASTH?
Analyst ratings for ASTH: 1 Buy, 12 Hold, 0 Sell — consensus Hold.
Did ASTH beat earnings?
ASTH last reported on Aug 6, 2026: EPS $0.40 vs $0.34 expected — a beat of 19.1%.
What is ASTH's P/E ratio?
ASTH trades at a P/E of 48.4 vs a Industrials average of 25.9.
Does ASTH pay a dividend?
Yes. ASTH's dividend yield is 0.65%.
What are ASTH support and resistance levels?
Support: $32.22, $29.33, $26.91. Resistance: $35.65, $38.77, $41.00.
What are insiders doing with ASTH?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on ASTH?
Nov 6, 2026: Needham keeps Buy rating on Astrana Health, lifts target to $45 · Nov 5, 2026: Astrana Health holds Q3 2026 earnings call